Trevi Therapeutics (NasdaqGM:TRVI) FY Conference September 09, 2025 04:05 PM ET Company ParticipantsFarrell Simon - CCOJennifer Good - CEO and co-founderConference Call ParticipantsJudah C. Frommer - AnalystJudah C. FrommerWelcome to this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from Trevi. Before I do that, let me read a quick disclosure statement. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com ...